Rutgers has granted Tonix Pharmaceutical exclusive worldwide rights to develop and commercialize a novel class of compounds ...

Epidermal growth factor receptor (EGFR) signaling in the tissue around oral cancers both increases nerve sensitivity and ...

New research suggests pain is not a simple signal of injury but a process that unfolds across nerves, spinal cord, and brain.

Add Yahoo as a preferred source to see more of our stories on Google. For the first time in two decades, the FDA has approved a new class of non-opioid pain medication, offering an alternative to ...

Scientists are developing a "sponge" that can soak up pain signals in the body before they reach the brain, potentially ...

A new study finds that an increasing number of surgeries — and the painkillers that follow — could derail recovery for those who once misused opioids.

Scientists are racing to redesign how powerful painkillers work, aiming to keep the relief that opioids provide while stripping away the worst dangers of addiction and overdose. Instead of tweaking ...

A study has shown that unlike opioids like morphine, the experimental painkiller does not cause tolerance, meaning you don't ...

(The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s ...

A new meta-analysis of 148 studies estimates that 9.3 percent of patients who receive opioid prescriptions for chronic pain experience "dependence" or "opioid use disorder" (D&OUD). The authors, Kyla ...

The opioid crisis remains a significant public health challenge in the United States. In 2022, over 2.5 million American adults had an opioid use disorder, and opioids accounted for nearly 76% of ...